Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Howard

Showing results (211-220 of 266) with videos related to

Pageof 27
Sort By:
Bjpsych Open|October 25, 2024
Cost-utility analysis of adapted problem adaptation therapy for depression in mild-to-moderate dementia caused by Alzheimer's disease: PATHFINDER randomised controlled trialMonica Panca, Robert Howard, Elizabeth Cort, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 13, 2019
Needs and preferences for psychological interventions of people with motor neuron diseaseKirsty R Weeks, Rebecca L Gould, Christopher Mcdermott, et al.
BMJ Open|March 1, 2022
PERFECTED enhanced recovery pathway (PERFECT-ER) versus standard acute hospital care for people after hip fracture surgery who have cognitive impairment: a feasibility cluster randomised controlled trialJane L Cross, Simon P Hammond, Lee Shepstone, et al.
International Journal of Geriatric Psychiatry|May 27, 2021
Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gapsKathy Y Liu, Robert Howard, Sube Banerjee, et al.
JAMA Neurology|November 19, 2019
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical TrialRobert Howard, Olga Zubko, Rosie Bradley, et al.
Genome Biology|September 8, 2015
A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health statusSanjana Sood, Iain J Gallagher, Katie Lunnon, et al.
BMJ (Clinical Research Ed.)|November 3, 2025
Everybody's business: call to all NHS staff to oppose the influence of racism and the far rightAlistair Stewart, Paul Fallon, Karen Reissmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 13, 2024
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trialRobert Howard, Elizabeth Cort, Charlotte Rawlinson, et al.
Advanced Healthcare Materials|May 12, 2026
Flash Assembloids: A Rapid Biofabrication of a Platform for Modeling Early Glioblastoma Invasion at the Glioblastoma-Brain Organoid InterfacesChao Liang, Henry Robert Howard, Shihui Chen, et al.
Lancet (London, England)|October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trialSube Banerjee, Juliet High, Susan Stirling, et al.
Pageof 27

Showing results (211-220 of 266) with videos related to

Sort By:
Pageof 27
Bjpsych Open|October 25, 2024
Cost-utility analysis of adapted problem adaptation therapy for depression in mild-to-moderate dementia caused by Alzheimer's disease: PATHFINDER randomised controlled trialMonica Panca, Robert Howard, Elizabeth Cort, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 13, 2019
Needs and preferences for psychological interventions of people with motor neuron diseaseKirsty R Weeks, Rebecca L Gould, Christopher Mcdermott, et al.
BMJ Open|March 1, 2022
PERFECTED enhanced recovery pathway (PERFECT-ER) versus standard acute hospital care for people after hip fracture surgery who have cognitive impairment: a feasibility cluster randomised controlled trialJane L Cross, Simon P Hammond, Lee Shepstone, et al.
International Journal of Geriatric Psychiatry|May 27, 2021
Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gapsKathy Y Liu, Robert Howard, Sube Banerjee, et al.
JAMA Neurology|November 19, 2019
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical TrialRobert Howard, Olga Zubko, Rosie Bradley, et al.
Genome Biology|September 8, 2015
A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health statusSanjana Sood, Iain J Gallagher, Katie Lunnon, et al.
BMJ (Clinical Research Ed.)|November 3, 2025
Everybody's business: call to all NHS staff to oppose the influence of racism and the far rightAlistair Stewart, Paul Fallon, Karen Reissmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 13, 2024
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trialRobert Howard, Elizabeth Cort, Charlotte Rawlinson, et al.
Advanced Healthcare Materials|May 12, 2026
Flash Assembloids: A Rapid Biofabrication of a Platform for Modeling Early Glioblastoma Invasion at the Glioblastoma-Brain Organoid InterfacesChao Liang, Henry Robert Howard, Shihui Chen, et al.
Lancet (London, England)|October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trialSube Banerjee, Juliet High, Susan Stirling, et al.
Pageof 27